Matthew Emmens, the chairman of pharma company Shire, has raised nearly £1.5m from a share sale.
Emmens sold 33,302 American Depositary Shares (ADSs) at an average price of $66.44. Each ADS is equivalent to three ordinary shares. The selling price was equivalent to £14.70 a share.
Last week, Emmens made a profit of £2.16m from the sale of options.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The share price has been strong since the US Food and Drug Administration granted marketing approval for VPRIV, a treatment for Gaucher disease, at the beginning of March.
Emmens retains 92,874 Shares and 60,861 ADSs - equivalent to a total of 275,457 shares.
Shire declared an interim dividend of 9.25 cents a share but the shares do not go ex-dividend until 10 March so Emmens will not be receiving the dividend on the shares he sold.
Emmens was chief executive of Shire between 2003 and 2008, when he was appointed chairman.
Shire reported a 2% decline in revenues to $2.69bn in 2009. Income after tax from continuing operations improved from $155.7m to $174.3m.
In the first quarter of the current year Shire expects revenues and earnings to be behind those seen in the corresponding period of 2009, reflecting the generic competition to Attention Deficit Hyperactivity Disorder drug Adderall XR.
Top Director Buys
GlobeOp Financial Services (GO.) Director name: Mr Edward AnnunziatoAmount purchased: 57,548 @ 250.00p Value: £143,870
Lloyds Banking Group (LLOY) Director name: Mr Anthony WatsonAmount purchased: 100,000 @ 53.09p Value: £53,090
Standard Chartered (STAN) Director name: Dr Han Seung-SooAmount purchased: 2,000 @ 1,721.30p Value: £34,426
Booker Group (BOK) Director name: Mrs Karen JonesAmount purchased: 50,000 @ 44.00p Value: £22,000
Top Director Sells
Shire Plc (SHP) Director name: Mr Matthew EmmensAmount sold: 99,906 @ 1,469.94p Value: £1,468,558
Telecity Group (TCY) Director name: Mr Brian McArthur MuscroftAmount sold: 349,995 @ 405.00p Value: £1,417,480
Schroder Asia Pacific Fund (SDP) Director name: The Rt. Ho the Earl of CromerAmount sold: 75,000 @ 180.50p Value: £135,375
Keller Group (KLR) Director name: Mr Robert RubrightAmount sold: 4,982 @ 651.50p Value: £32,458
DS Smith (SMDS) Director name: Mr Stephen William DrydenAmount sold: 15,820 @ 125.40p Value: £19,838
-
Four AI ETFs to buyIs now a good time to buy AI ETFs? We examine four AI ETFs that investors might want to add to their portfolio
-
Chase boosts easy-access interest rate - savers could earn 4.75%Chase is offering a boosted interest rate which is fixed for six months, on top of the standard variable rate
